Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.

Autor: Shahzadi A; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. shahzadiandleeb@yahoo.com., Eyileten C; Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.; Genomics Core Facility, Center of New Technologies, University of Warsaw, Warsaw, Poland., Postula M; Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Tanoglu EG; Department of Molecular Biology and Genetics, Institution of Hamidiye Health Sciences, University of Health Sciences Turkey, Istanbul, Turkey., Karatas OF; Department of Molecular Biology and Genetics, Erzurum Technical University, Erzurum, Turkey., Basci AB; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey., Suzer O; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey., Yazici Z; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. zyazici@biruni.edu.tr.; Department of Medical Pharmacology, Faculty of Medicine, Biruni University, Istanbul, Turkey. zyazici@biruni.edu.tr.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2023 Jul; Vol. 396 (7), pp. 1547-1561. Date of Electronic Publication: 2022 Nov 23.